Please login to the form below

Lemtrada

This page shows the latest Lemtrada news and features for those working in and with pharma, biotech and healthcare.

the disease if they have failed to respond to first-line treatment with Sanofi's Lemtrada (alemtuzumab) or have rapidly evolving severe MS.

Celebrating excellence

The London-based agency picked up The Cello Health Award for Launch Excellence for work on behalf of Genzyme and its multiple sclerosis treatment Lemtrada. ... Lucid also picked up the Cello Health Award for Launch Excellence Award for supporting Genzyme
Lucid behavioural change programmes recognised at PMEA

The London-based agency picked The Cello Health Award for Launch Excellence for work on behalf of Genzyme and its multiple sclerosis treatment Lemtrada. ... Lucid also picked up the Cello Health Award for Launch Excellence Award for supporting Genzyme
Sanofi forges $1.5bn cancer partnership with BioNTech

and Lemtrada (alemtuzumab) and subsidiary Genzyme's rare disease portfolio.
Sanofi plans 18 new product launches by 2020

The remainder of its growth portfolio are Cerdelga (eliglustat) for Gaucher disease - the only approved oral, first-line therapy for the rare genetic disease, Lemtrada (alemtuzumab) for multiple sclerosis and sarilumab,
Sanofi persuades FDA to back its MS drug Lemtrada

well-controlled studies that demonstrate the benefits of Lemtrada outweigh its serious adverse effects". ... Lemtrada demonstrated superior efficacy over Rebif on annualised relapse rates in the two studies which were the basis for approval.”.

More from news
Approximately 8 fully matching, plus 25 partially matching documents found.

Executive changes at Sanofi

such as Aubagio (teriflunomide) and Lemtrada (alemtuzumab). “

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Client Services Director – Medical Education Agency – North West...: Salary TBC

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Add my company

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?: What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma: Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies: Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...